Description
Our objective is to examine “coverage, price, and reimbursement” (“CPR”) for multigene tests broadly and for cancer-related indications, specifically, why tests are covered/not covered by payers, how this is changing over time, and how CPR influences testing decisions and practices in clinic settings.
Prime PI is Kathryn A. Phillips, Ph.D., UCSF. Site PI is Su-Ying Liang, Ph.D.
Principal Investigator
Funder
National Institutes of Health - National Cancer Institute
Research Topics
Related Studies
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator, Monique de Bruin, M.D., MPH
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Develop an app that support access to clinical data and shared decision-making, predict disease course, and guide disease management.
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Risk-Benefit Trade-Offs for Whole Genome Sequencing
Describe the clinical pathway of genetic testing at PAMF, and assess and obtain preliminary data on the use of genetic tests at PAMF.
Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Understanding the Experiences of Patients Undergoing Genetic Counseling and Testing for BRCA
This project investigates how patients deliberate, decide, & act upon genetic counseling & testing to determine their personal risk for breast & ovarian cancer.
Genetics and Comorbidity of Migraine
Identify common genetic variants for migraine to determine whether there are single nucleotide polymorphisms associated with migraine.